A detailed history of Arizona State Retirement System transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Arizona State Retirement System holds 73,934 shares of VRTX stock, worth $33.3 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
73,934
Previous 74,884 1.27%
Holding current value
$33.3 Million
Previous $35.1 Million 2.03%
% of portfolio
0.22%
Previous 0.24%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$460.0 - $505.78 $437,000 - $480,491
-950 Reduced 1.27%
73,934 $34.4 Million
Q2 2024

Aug 05, 2024

BUY
$392.81 - $485.53 $368,062 - $454,941
937 Added 1.27%
74,884 $35.1 Million
Q1 2024

May 07, 2024

BUY
$407.69 - $446.08 $543,858 - $595,070
1,334 Added 1.84%
73,947 $30.9 Million
Q4 2023

Jan 24, 2024

SELL
$343.0 - $410.68 $98,784 - $118,275
-288 Reduced 0.4%
72,613 $29.5 Million
Q3 2023

Nov 06, 2023

SELL
$338.18 - $362.46 $246,871 - $264,595
-730 Reduced 0.99%
72,901 $25.4 Million
Q2 2023

Aug 01, 2023

BUY
$314.42 - $351.91 $1.11 Million - $1.25 Million
3,544 Added 5.06%
73,631 $25.9 Million
Q1 2023

Apr 27, 2023

BUY
$283.23 - $323.1 $59,478 - $67,851
210 Added 0.3%
70,087 $22.1 Million
Q4 2022

Feb 07, 2023

BUY
$285.76 - $321.48 $101,730 - $114,446
356 Added 0.51%
69,877 $20.2 Million
Q3 2022

Nov 07, 2022

SELL
$273.83 - $305.53 $87,899 - $98,075
-321 Reduced 0.46%
69,521 $20.1 Million
Q2 2022

Jul 28, 2022

BUY
$234.96 - $292.55 $17,856 - $22,233
76 Added 0.11%
69,842 $19.7 Million
Q1 2022

May 04, 2022

SELL
$221.42 - $260.97 $284,746 - $335,607
-1,286 Reduced 1.81%
69,766 $18.2 Million
Q4 2021

Feb 04, 2022

SELL
$177.01 - $223.45 $201,083 - $253,839
-1,136 Reduced 1.57%
71,052 $15.6 Million
Q3 2021

Nov 12, 2021

SELL
$181.39 - $202.99 $117,177 - $131,131
-646 Reduced 0.89%
72,188 $13.1 Million
Q2 2021

Aug 02, 2021

SELL
$187.49 - $221.1 $83,620 - $98,610
-446 Reduced 0.61%
72,834 $14.7 Million
Q1 2021

May 06, 2021

SELL
$207.02 - $241.31 $386,506 - $450,525
-1,867 Reduced 2.48%
73,280 $15.7 Million
Q4 2020

Jan 28, 2021

SELL
$207.01 - $276.09 $1.23 Million - $1.63 Million
-5,918 Reduced 7.3%
75,147 $17.8 Million
Q3 2020

Nov 05, 2020

BUY
$255.65 - $303.1 $5.15 Million - $6.11 Million
20,161 Added 33.1%
81,065 $22.1 Million
Q2 2020

Aug 04, 2020

BUY
$225.48 - $295.8 $3.31 Million - $4.34 Million
14,668 Added 31.72%
60,904 $17.7 Million
Q1 2020

May 05, 2020

SELL
$199.77 - $247.81 $409,528 - $508,010
-2,050 Reduced 4.25%
46,236 $11 Million
Q4 2019

Jan 27, 2020

BUY
$166.71 - $223.91 $48,512 - $65,157
291 Added 0.61%
48,286 $10.6 Million
Q3 2019

Oct 31, 2019

SELL
$166.23 - $187.09 $119,186 - $134,143
-717 Reduced 1.47%
47,995 $8.13 Million
Q2 2019

Jul 25, 2019

SELL
$164.61 - $190.37 $62,387 - $72,150
-379 Reduced 0.77%
48,712 $8.93 Million
Q1 2019

Apr 29, 2019

SELL
$163.73 - $194.7 $559,465 - $665,289
-3,417 Reduced 6.51%
49,091 $9.03 Million
Q4 2018

Jan 28, 2019

SELL
$151.91 - $192.21 $1.65 Million - $2.08 Million
-10,834 Reduced 17.1%
52,508 $8.7 Million
Q3 2018

Oct 29, 2018

BUY
$167.73 - $192.74 $119,088 - $136,845
710 Added 1.13%
63,342 $12.2 Million
Q2 2018

Aug 07, 2018

SELL
$145.72 - $169.96 $2.14 Million - $2.5 Million
-14,720 Reduced 19.03%
62,632 $10.6 Million
Q1 2018

May 14, 2018

SELL
$151.6 - $177.13 $166,760 - $194,843
-1,100 Reduced 1.4%
77,352 $12.6 Million
Q4 2017

Feb 09, 2018

BUY
$137.28 - $155.55 $409,506 - $464,005
2,983 Added 3.95%
78,452 $11.8 Million
Q3 2017

Nov 14, 2017

BUY
$148.13 - $162.24 $11.2 Million - $12.2 Million
75,469
75,469 $11.5 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.